hepatitis news and views from SA
Author Hepatitis SAPosted on Categories 2023 WinterLeave a comment on HR 23: Strength In Solidarity – Part 1 By Carol Holly
The Harm Reduction conference is held in a different country every two years and provides a forum for sharing the latest research, programs and policy in drug use, harm reduction* and human rights. The conference is convened by Harm Reduction International (HRI) – an organisation that promotes harm reduction and rights-based, evidence-based responses to drug use.
Author James MorrisonPosted on Categories 2023 WinterLeave a comment on Hep C Treatment Barriers for Rural Aboriginal South Australians The rate of hepatitis C infections in Aboriginal and Torres Strait Islander communities in Australia is increasing even as infection rate decreases in the wider community. This is despite the introduction of direct-acting antiviral (DAA) drugs that offer the chance to completely eliminate the hepatitis C virus (HCV).
Continue reading “Hep C Treatment Barriers for Rural Aboriginal South Australians”
Author James MorrisonPosted on Categories 2023 WinterLeave a comment on Creating a Hep C Home Test—with AI Going beyond pregnancy and COVID-19, the world could someday soon come to rely on at-home tests for many diseases thanks in part to AI-fuelled improvements. University of Florida (UF) scientists have used artificial intelligence tools to simplify a test that works for both hepatitis C and SARS-CoV-2, the virus that causes COVID-19. The simplified test happens in one small test tube in just a few minutes. With further refinement, it could come to doctor’s offices soon and, one day, even home tests that are as easy as a pregnancy test.
Chronic hepatitis C virus (HCV) infection affects around 3.5 million children worldwide, and in Australia, it’s estimated that it affects at least 4 children per million under 15 years old. Children with chronic hepatitis C infection can suffer from reduced quality of life, social stigmatisation, and inadequate access to specialist care. As with adults, the disease can progress to hepatic fibrosis, chronic liver disease, and hepatocellular cancer.
Author James MorrisonPosted on Categories UncategorisedLeave a comment on More Evidence of DAAs’ Power for Elimination A recent large-scale study confirms that treating chronic hepatitis C patients with direct-acting antivirals (DAA) leads to improved outcomes and better long-term survival.
Continue reading “More Evidence of DAAs’ Power for Elimination”
Author Cecilia LimPosted on Categories UncategorisedLeave a comment on 10 Ways to Reduce Blood-Borne Viruses in Prisons Clean needle program tops the list of strategies outlined in a consensus statement released by the Harm Reduction in Prisons Working Group. The statement aims to provide a clear, concise overview of evidence-based harm reduction interventions needed to reduce injecting-related harms in Australian prisons.
Continue reading “10 Ways to Reduce Blood-Borne Viruses in Prisons”
